Ovarian

Could current trials hold promise for a major shift in the way we treat ovarian cancer?

Associate Professor Tarek Meniawy, Chair of the Ovarian Cancer Tumour Group, talks about recent advances in drug therapy, and why current trials underway hold promise for a major shift in standard practice and improved outcomes for [...]

Could current trials hold promise for a major shift in the way we treat ovarian cancer?2020-06-03T04:29:21+10:00
Go to Top